









Mercado
/
Acciones
/
nasdaq-livn
/

LivaNova PLC

LIVN

42.530USD

+1.400+3.40%

Horarios del mercado （ET）Cotizaciones retrasadas 15 min

2.32BCap. mercado

PérdidaP/E TTM



LivaNova PLC

42.530

+1.400+3.40%

Descripción general Compañía Finanzas

LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the design, development, manufacture, marketing and selling of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula and other related accessories. It includes the Essenz Perfusion System, the Company’s next-generation HLM with an embedded patient monitor for tailored patient care strategies. Neuromodulation segment is engaged in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). The ACS segment is engaged in the development, production, and sale of temporary life support products.

Información de la empresa

Símbolo de cotizaciónLIVN

Nombre de la empresaLivaNova PLC

Fecha de salida a bolsaOct 19, 2015

Director ejecutivoMr. Vladimir A. Makatsaria

Número de empleados2900

Tipo de seguridadOrdinary Share

Fin del año fiscalOct 19

Dirección20 Eastbourne Terrace

CiudadLONDON

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited Kingdom

Código postalW2 6LG

Teléfono442033250662

Sitio Webhttps://www.livanova.com/

Símbolo de cotizaciónLIVN

Fecha de salida a bolsaOct 19, 2015

Director ejecutivoMr. Vladimir A. Makatsaria

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. William A. Kozy

Independent Chairman of the Board

32.57K

+15.05%

Mr. Alex Shvartsburg

Chief Financial Officer

26.68K

Ms. Stephanie Bolton

President, Global Epilepsy

12.75K

Dr. Sharon O'Kane, Ph.D.

Independent Director

11.30K

+19.06%

Mr. Francesco Bianchi

Independent Director

10.53K

+39.96%

Mr. Todd C. Schermerhorn

Independent Director

9.06K

+49.63%

Franco Poletti ,

President, Cardiopulmonary Business Unit

8.15K

+2.76%

Ms. Brooke Story

Independent Director

6.48K

+86.48%

Mr. Michael Damon Hutchinson

Senior Vice President, Chief Legal Officer, Company Secretary

5.67K

Ahmet Tezel

Senior Vice President, Chief Innovation Officer

1.94K

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. William A. Kozy

Independent Chairman of the Board

32.57K

+15.05%

Mr. Alex Shvartsburg

Chief Financial Officer

26.68K

Ms. Stephanie Bolton

President, Global Epilepsy

12.75K

Dr. Sharon O'Kane, Ph.D.

Independent Director

11.30K

+19.06%

Mr. Francesco Bianchi

Independent Director

10.53K

+39.96%

Mr. Todd C. Schermerhorn

Independent Director

9.06K

+49.63%

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de jul

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Sin datos

Por regiónUSD

Nombre

Ganancia

Proporción

United States

169.16M

53.39%

Rest of World

87.99M

27.77%

Europe

59.70M

18.84%

Por negocio

Por región

Sin datos

Estadísticas de accionistas

Actualizado: sáb., 17 de may

Accionistas

Tipos de accionistas

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

11.97%

PRIMECAP Management Company

8.45%

The Vanguard Group, Inc.

4.87%

State Street Global Advisors (US)

3.85%

Capital Research Global Investors

3.81%

Other

67.05%

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

11.97%

PRIMECAP Management Company

8.45%

The Vanguard Group, Inc.

4.87%

State Street Global Advisors (US)

3.85%

Capital Research Global Investors

3.81%

Other

67.05%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

50.40%

Investment Advisor/Hedge Fund

30.34%

Hedge Fund

15.63%

Research Firm

3.10%

Pension Fund

1.48%

Bank and Trust

1.30%

Venture Capital

0.73%

Individual Investor

0.38%

Sovereign Wealth Fund

0.22%

Participación institucional

Actualizado: mar., 1 de jul

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q2

563

56.51M

103.64%

-7.03M

2025Q1

581

56.61M

103.82%

-8.04M

2024Q4

586

56.98M

104.84%

-8.56M

2024Q3

563

55.15M

101.56%

-9.48M

2024Q2

546

57.21M

105.64%

-8.52M

2024Q1

547

58.00M

107.51%

-6.90M

2023Q4

532

56.62M

105.11%

-7.28M

2023Q3

527

56.14M

104.20%

-8.51M

2023Q2

529

55.56M

103.33%

-9.55M

2023Q1

544

57.05M

106.52%

-4.67M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

6.53M

11.97%

-36.05K

-0.55%

Mar 31, 2025

PRIMECAP Management Company

4.61M

8.45%

-145.65K

-3.06%

Mar 31, 2025

The Vanguard Group, Inc.

2.65M

4.87%

+316.99K

+13.56%

Mar 31, 2025

State Street Global Advisors (US)

2.10M

3.85%

-950.00

-0.05%

Mar 31, 2025

Capital Research Global Investors

2.08M

3.81%

+465.61K

+28.87%

Mar 31, 2025

Millennium Management LLC

2.07M

3.79%

-983.66K

-32.27%

Mar 31, 2025

AQR Capital Management, LLC

1.57M

2.88%

+829.12K

+111.71%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.41M

2.59%

+73.94K

+5.53%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

1.33M

2.44%

+20.96K

+1.60%

Mar 31, 2025

Emerald Advisers LLC

1.22M

2.24%

-5.17K

-0.42%

Mar 31, 2025

ETFs relacionados

Actualizado: sáb., 2 de ago

Nombre

Proporción

SPDR S&P Health Care Equipment ETF

1.76%

JPMorgan Active Small Cap Value ETF

1.01%

Invesco NASDAQ Future Gen 200 ETF

0.47%

Global X Aging Population ETF

0.35%

Federated Hermes MDT Small Cap Core ETF

0.31%

Avantis US Small Cap Equity ETF

0.31%

Simplify Health Care ETF

0.29%

iShares U.S. Medical Devices ETF

0.28%

First Trust Active Factor Mid Cap ETF

0.26%

WisdomTree US SmallCap Fund

0.25%

SPDR S&P Health Care Equipment ETF

Proporción1.76%

JPMorgan Active Small Cap Value ETF

Proporción1.01%

Invesco NASDAQ Future Gen 200 ETF

Proporción0.47%

Global X Aging Population ETF

Proporción0.35%

Federated Hermes MDT Small Cap Core ETF

Proporción0.31%

Avantis US Small Cap Equity ETF

Proporción0.31%

Simplify Health Care ETF

Proporción0.29%

iShares U.S. Medical Devices ETF

Proporción0.28%

First Trust Active Factor Mid Cap ETF

Proporción0.26%

WisdomTree US SmallCap Fund

Proporción0.25%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

